/ Merck

/ Market Analysis

Merck’s Stock Rises Amid New Cancer Treatment Drug Breakthrough

MSD's new injectable Keytruda formulation offers similar effectiveness to the intravenous version, potentially halving treatment time.

March 28, 2025

Big Pharma Stocks: Who’s Leading the Race and Who’s Slipping?

Merck's wider drug moat and acquisition spree makes it a safer bet but VKTX can be the next LLY.

August 20, 2024

Three Solid Stocks That Still Have Plenty of Growth Left

Which companies are positioned for greater growth?

November 20, 2023